Target intelligence / Profile preview

G protein-activated inwardly rectifying potassium channel (GIRK) (GIRK)

Target
GIRK
Molecular classification
Ion channel, Inwardly rectifying potassium channel
01

Overview

G protein-activated inwardly rectifying potassium (GIRK) channels are a family of lipid-gated ion channels that play a fundamental role in regulating cellular excitability across the nervous system and the heart [1.1.1, 1.4.1]. These channels are primarily activated by the Gβγ subunits of inhibitory G proteins (Gi/o) following the stimulation of various G protein-coupled receptors (GPCRs), such as opioid, muscarinic M2, and GABA-B receptors [1.1.1, 1.4.3]. Upon activation, GIRK channels allow the efflux of potassium ions, leading to membrane hyperpolarization and a subsequent decrease in the firing rate of neurons or pacemaker cells [1.1.2, 1.4.1]. Dysregulation of GIRK channel activity is implicated in a wide range of pathologies, including epilepsy, chronic pain, drug addiction, and cardiac arrhythmias like atrial fibrillation [1.2.1, 1.2.2]. Consequently, they are viewed as promising therapeutic targets; activators are being explored for their anticonvulsant and analgesic properties, while selective blockers are under investigation for treating heart rhythm disorders [1.3.1, 1.4.4]. However, the development of GIRK-targeted therapies faces challenges related to subunit selectivity and the potential for off-target effects in the heart or brain [1.2.2, 1.4.5].

Other names
Kir3Kir3.1Kir3.2Kir3.3Kir3.4KCNJ3KCNJ6KCNJ9KCNJ5G protein-gated inwardly rectifying potassium channel
02

Mechanism of action

GIRK channels are activated by G-protein beta-gamma subunits following GPCR stimulation, leading to potassium efflux and membrane hyperpolarization, which inhibits cellular firing [1.1.1, 1.4.1].

03

Biological functions

Signal transductionMembrane potential regulationNeuronal inhibitionHeart rate regulationSynaptic transmission
04

Disease associations

EpilepsyAtrial fibrillationAddictionChronic painAnxietyParkinson's diseaseDown's syndromeKeppen-Lubinsky syndromePrimary hyperaldosteronism
05

Safety considerations

Pro-arrhythmic effectsSedationMotor impairmentAddiction liability
06

Interacting drugs

Ethanol

10 more in the full profile.

07

Biomarkers

Plasma aldosterone levelsElectrocardiogram (ECG) parameters

Beyond the preview

Go deeper on G protein-activated inwardly rectifying potassium channel (GIRK) (GIRK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-activated inwardly rectifying potassium channel (GIRK) (GIRK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call